Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00227_DB01149_nanopub.RAqlwidO90CpewvAW81M09I62U166hZxBR5kS_ut3Tp8Q#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00227_DB01149 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00227_DB01149 label "DDI between Lovastatin and Nefazodone - Nefazodone, a strong CYP3A4 inhibitor, may increase the serum concentration of lovastatin by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of lovastatin if nefazodone is initiated, discontinued or dose changed. [drugbank_resource:DB00227_DB01149]" assertion.
- drugbank_resource:DB00227_DB01149 identifier "drugbank_resource:DB00227_DB01149" assertion.
- drugbank_resource:DB00227_DB01149 title "DDI between Lovastatin and Nefazodone - Nefazodone, a strong CYP3A4 inhibitor, may increase the serum concentration of lovastatin by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of lovastatin if nefazodone is initiated, discontinued or dose changed." assertion.
- drugbank:DB01149 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00227_DB01149 assertion.
- drugbank:DB00227 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00227_DB01149 assertion.